BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yoo JY, Yeh M, Kaur B, Lee TJ. Targeted delivery of small noncoding RNA for glioblastoma. Cancer Lett 2021;500:274-80. [PMID: 33176185 DOI: 10.1016/j.canlet.2020.11.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Robinson EL, Port JD. Utilization and Potential of RNA-Based Therapies in Cardiovascular Disease. JACC: Basic to Translational Science 2022. [DOI: 10.1016/j.jacbts.2022.02.003] [Reference Citation Analysis]
2 Cox A, Lim SA, Chung EJ. Strategies to deliver RNA by nanoparticles for therapeutic potential. Mol Aspects Med 2021;:100991. [PMID: 34366123 DOI: 10.1016/j.mam.2021.100991] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Duskey JT, Rinaldi A, Ottonelli I, Caraffi R, De Benedictis CA, Sauer AK, Tosi G, Vandelli MA, Ruozi B, Grabrucker AM. Glioblastoma Multiforme Selective Nanomedicines for Improved Anti-Cancer Treatments. Pharmaceutics 2022;14:1450. [DOI: 10.3390/pharmaceutics14071450] [Reference Citation Analysis]
4 Guo L, Shi D, Shang M, Sun X, Meng D, Liu X, Zhou X, Li J. Utilizing RNA nanotechnology to construct negatively charged and ultrasound-responsive nanodroplets for targeted delivery of siRNA. Drug Delivery 2022;29:316-27. [DOI: 10.1080/10717544.2022.2026532] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Li N, Sun Y, Fu Y, Sun K. RNA Drug Delivery Using Biogenic Nanovehicles for Cancer Therapy. Front Pharmacol 2021;12:734443. [PMID: 35002692 DOI: 10.3389/fphar.2021.734443] [Reference Citation Analysis]